Reata Pharmaceuticals Inc. is withdrawing a registration statement for the sale of up to $86.3 million worth of class A common shares.
The shelf registration was filed earlier this month and is being withdrawn due to "unfavorable market conditions."
Reata Pharmaceuticals withdraws $86.3M stock offering
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Reata Pharmaceuticals withdraws $86.3M stock offering
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals